“When you put … the pedal to the floor, you can get it done,” Fauci told CNN’s Chris Cuomo on Thursday night.
And Fauci said Friday he believes the US can go faster than 1 million shots per day.
“I’d like it to be a lot more,” Fauci told CNN’s John Berman. “The goal (of 100 million shots in 100 days) was set, but you don’t want to get fixated on, ‘Was that an undershoot or an overshoot?’
“If we can do better than that, which I personally think we likely will, then great.”
The US recently recorded 1 million new shots in a 24-hour period, according to changes in US Centers for Disease Control and Prevention data from Wednesday morning to Thursday morning. That’s only the second time a one-day increase rose above 1 million.
Fauci’s assessment offers a glimmer of hope as the country has reported an average of 3,050 Covid-19 deaths a day over the last week. Forecasts predict the nation’s death toll will likely top 500,000 within the next month.
It also comes as new case levels, though sky-high compared to most of the pandemic, have been dipping recently.
The US has averaged about 187,590 new cases a day over the last week — down nearly 25% from the all-time peak average reached just 11 days ago, but still 2.8 times higher than the summer’s peak in July, Johns Hopkins University data shows.
The CDC recently warned that new, more contagious virus variants — like the one first identified in the UK — could still accelerate the spread of the virus.
Fauci said Friday that a more transmissible variant isn’t yet dominant in the United States, and he’s “not exactly sure” that it will drive a surge in cases, but it has to be watched carefully.
“The best thing you can do about that is to continue to uniformly adhere to the public health recommendations that we’ve spoken about time and again — from the wearing of masks to the washing of hands to avoiding congregate settings,” Fauci said. “That’s the kind of thing that prevents surges regardless of what the type of virus … is there.”
Seniors spend hours waiting in Los Angeles
More than 15 million people in the US have received at least one shot of a Covid-19 vaccine. Almost 2.4 million of them received a second dose, according to CDC data last updated Thursday morning.
Some state and local officials say they aren’t getting the vaccines fast enough to meet demand.
In Georgia, officials are seeing high numbers of cases, hospitalizations and deaths, and the 120,000 doses allotted per week to the state is not enough to vaccinate seniors and other high-risk residents, Gov. Brian Kemp said.
“We will still have far more demand than we have supply,” Kemp said.
Constraints on supply in New York City means there are not enough doses to vaccinate members of the city’s police and fire departments, the agencies told CNN on Thursday. There are still enough for those who already have appointments made and those who had already received their first dose, the fire department said.
Lines at Los Angeles’ Dodger Stadium on Thursday were filled largely with people over 65 years old, with some waiting for five hours for the vaccine, Mayor Eric Garcetti said.
“There may be a wait … so use the restroom beforehand, bring water and snacks, and make sure your gas tank is filled up or your car is charged,” he said.
Biden’s pick for Surgeon General, Dr. Vivek Murthy, said the US needs to do more to speed up the vaccinations.
“We cannot take a year in order to get to the critical levels of vaccination that we need in this country,” Murthy told CNN’s Wolf Blitzer on Thursday. “We’ve got to get there sooner.”
Even with reports of many people waiting in line, about six in 10 Americans don’t know when or where to get a coronavirus vaccine, according to a new report from the Kaiser Family Foundation.
Most Americans don’t know when or where they can get a vaccine, including older Americans, who are already eligible to get a vaccine in a growing number of states,” foundation President and CEO Drew Altman said in a news release Friday. “Understandably large numbers of people are frustrated, angry and confused.”
The Biden administration will “try to build … (a) national clearinghouse” that provides information on where people can get shots, said White House chief of staff Ron Klain on Thursday night.
“It needs to be earlier and more transparent for people to figure out how to get their shot and where to get their shot,” Klain told MSNBC’s Lawrence O’Donnell.
New vaccines could be on the way
Officials hope new coronavirus vaccines will be approved and help speed up the administration.
Currently, the US has approved vaccines by Pfizer and Moderna.
However, Johnson & Johnson, assuming it receives FDA approval, plans to have “enough vaccines for 100 million Americans by spring,” board member Dr. Mark McClellan told CNBC on Thursday.
Fauci said the company’s vaccine is “right around the corner” from seeking emergency use authorization from the FDA.
“They’re probably a couple of weeks away from getting the data looked at, to have the FDA evaluate whether or not we’re in a situation where we could move ahead and start thinking about getting it out into the public,” he said Thursday.
That candidate would come with advantages, including that it would be a single shot, and that it doesn’t require storage at extremely low temperatures, he said.
As for another candidate in Phase 3 trials, from AstraZeneca, that is “a bit behind, but not too far behind,” Fauci said.
Last week, the federal government’s Operation Warp Speed program’s chief adviser said he hoped the AstraZeneca candidate, if data shows it to be effective, could receive US authorization by the end of March.
“Hopefully the vaccine again is efficacious, as has been shown in the trials conducted in Brazil and in the UK,” said Operation Warp Speed chief science adviser Moncef Slaoui. “So maybe an approval somewhere towards the latter part of the month of March, and a significant number of doses available around that time.”
CNN’s Lindsay Benson, Maria Cartaya, Andrea Diaz, Jacqueline Howard, Lauren Mascarenhas, Deidre McPhillips, Alexandra Meeks, Michael Nedelman, Evan Simko-Bednarski and Naomi Thomas contributed to this report.